HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cochlear Implantation in a Patient with Neurofibromatosis Type 2 and an Intracochlear Schwannoma: A Case Report and Literature Review.

Abstract
A primary intracochlear schwannoma (ICS) is a unique type of vestibular schwannoma (VS); the tumor originates from the terminal branches of the cochlear nerve and is confined to the cochlea. An ICS is the most common subtype of schwannoma in the inner ear. As an ICS is clinically rare, diagnosis and treatment remain challenging. We report a rare case of cochlear implantation (CI) in a patient with neurofibromatosis type 2 and an ICS. The patient exhibited bilateral, profound, sensorineural hearing loss. The tumor on one side was a common VS treated via tumor and acoustic nerve resection and that on the other side an ICS. To ensure auditory rehabilitation via CI, we performed CI while removing part of the ICS via an enlarged round window. Auditory rehabilitation was satisfactory. Thus, ICS patients, especially those who urgently require auditory rehabilitation, can undergo simultaneous CI and (total or partial) tumor removal. However, the long-term results require close observation.
AuthorsDejun Zhang, Zeming Fu, Shuang Han, Fang Guo, Na Tang, Ying Zhao, Guofang Guan
JournalORL; journal for oto-rhino-laryngology and its related specialties (ORL J Otorhinolaryngol Relat Spec) Vol. 84 Issue 5 Pg. 425-428 ( 2022) ISSN: 1423-0275 [Electronic] Switzerland
PMID35537404 (Publication Type: Case Reports, Review)
Copyright© 2022 S. Karger AG, Basel.
Topics
  • Cochlear Implantation (methods)
  • Cochlear Nerve (surgery)
  • Hearing Loss, Sensorineural (etiology, surgery)
  • Humans
  • Neurilemmoma (complications, surgery)
  • Neurofibromatosis 2 (complications, diagnosis, surgery)
  • Neuroma, Acoustic (complications, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: